Interparfums (IPAR) Competitors

Interparfums has a beta of 1.12, indicating that its share price is 12% more volatile than the broader market. Comparatively, Coty has a beta of 0.95, indicating that its share price is 5% less volatile than the broader market.

55.6% of Interparfums shares are owned by institutional investors. Comparatively, 42.4% of Coty shares are owned by institutional investors. 43.6% of Interparfums shares are owned by company insiders. Comparatively, 5.9% of Coty shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Interparfums has higher earnings, but lower revenue than Coty. Coty is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

In the previous week, Coty had 7 more articles in the media than Interparfums. MarketBeat recorded 11 mentions for Coty and 4 mentions for Interparfums. Interparfums' average media sentiment score of 1.39 beat Coty's score of 0.27 indicating that Interparfums is being referred to more favorably in the media.

Interparfums currently has a consensus target price of $123.29, indicating a potential upside of 10.61%. Coty has a consensus target price of $3.39, indicating a potential upside of 26.32%. Given Coty's higher possible upside, analysts plainly believe Coty is more favorable than Interparfums.

Interparfums has a net margin of 11.17% compared to Coty's net margin of -10.42%. Interparfums' return on equity of 15.21% beat Coty's return on equity.

Interparfums has a net margin of 11.17% compared to e.l.f. Beauty's net margin of 3.38%. Interparfums' return on equity of 15.21% beat e.l.f. Beauty's return on equity.

Interparfums presently has a consensus target price of $123.29, indicating a potential upside of 10.61%. e.l.f. Beauty has a consensus target price of $92.13, indicating a potential downside of 8.28%. Given Interparfums' higher probable upside, equities research analysts plainly believe Interparfums is more favorable than e.l.f. Beauty.

55.6% of Interparfums shares are held by institutional investors. Comparatively, 92.4% of e.l.f. Beauty shares are held by institutional investors. 43.6% of Interparfums shares are held by insiders. Comparatively, 3.5% of e.l.f. Beauty shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Interparfums has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market. Comparatively, e.l.f. Beauty has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

Interparfums has higher earnings, but lower revenue than e.l.f. Beauty. Interparfums is trading at a lower price-to-earnings ratio than e.l.f. Beauty, indicating that it is currently the more affordable of the two stocks.

In the previous week, e.l.f. Beauty had 11 more articles in the media than Interparfums. MarketBeat recorded 15 mentions for e.l.f. Beauty and 4 mentions for Interparfums. Interparfums' average media sentiment score of 1.39 beat e.l.f. Beauty's score of 1.03 indicating that Interparfums is being referred to more favorably in the media.

Interparfums has a beta of 1.12, meaning that its share price is 12% more volatile than the broader market. Comparatively, Lamb Weston has a beta of 0.47, meaning that its share price is 53% less volatile than the broader market.

Interparfums has a net margin of 11.17% compared to Lamb Weston's net margin of 4.39%. Lamb Weston's return on equity of 23.33% beat Interparfums' return on equity.

55.6% of Interparfums shares are owned by institutional investors. Comparatively, 89.6% of Lamb Weston shares are owned by institutional investors. 43.6% of Interparfums shares are owned by company insiders. Comparatively, 1.0% of Lamb Weston shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Interparfums presently has a consensus target price of $123.29, indicating a potential upside of 10.61%. Lamb Weston has a consensus target price of $53.36, indicating a potential upside of 11.04%. Given Lamb Weston's higher probable upside, analysts clearly believe Lamb Weston is more favorable than Interparfums.

Interparfums pays an annual dividend of $3.20 per share and has a dividend yield of 2.9%. Lamb Weston pays an annual dividend of $1.52 per share and has a dividend yield of 3.2%. Interparfums pays out 61.2% of its earnings in the form of a dividend. Lamb Weston pays out 73.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Interparfums has increased its dividend for 4 consecutive years and Lamb Weston has increased its dividend for 7 consecutive years. Lamb Weston is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Lamb Weston has higher revenue and earnings than Interparfums. Interparfums is trading at a lower price-to-earnings ratio than Lamb Weston, indicating that it is currently the more affordable of the two stocks.

In the previous week, Lamb Weston had 3 more articles in the media than Interparfums. MarketBeat recorded 7 mentions for Lamb Weston and 4 mentions for Interparfums. Lamb Weston's average media sentiment score of 1.46 beat Interparfums' score of 1.39 indicating that Lamb Weston is being referred to more favorably in the news media.

Interparfums pays an annual dividend of $3.20 per share and has a dividend yield of 2.9%. Medifast pays an annual dividend of $6.60 per share and has a dividend yield of 54.4%. Interparfums pays out 61.2% of its earnings in the form of a dividend. Medifast pays out -283.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Interparfums has increased its dividend for 4 consecutive years. Medifast is clearly the better dividend stock, given its higher yield and lower payout ratio.

55.6% of Interparfums shares are held by institutional investors. Comparatively, 95.5% of Medifast shares are held by institutional investors. 43.6% of Interparfums shares are held by insiders. Comparatively, 3.7% of Medifast shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Interparfums had 1 more articles in the media than Medifast. MarketBeat recorded 4 mentions for Interparfums and 3 mentions for Medifast. Interparfums' average media sentiment score of 1.39 beat Medifast's score of 0.52 indicating that Interparfums is being referred to more favorably in the media.

Interparfums has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

Interparfums currently has a consensus price target of $123.29, indicating a potential upside of 10.61%. Medifast has a consensus price target of $12.00, indicating a potential downside of 1.11%. Given Interparfums' stronger consensus rating and higher possible upside, analysts clearly believe Interparfums is more favorable than Medifast.

Interparfums has a beta of 1.12, meaning that its share price is 12% more volatile than the broader market. Comparatively, Medifast has a beta of 0.71, meaning that its share price is 29% less volatile than the broader market.

Interparfums has a net margin of 11.17% compared to Medifast's net margin of -8.08%. Interparfums' return on equity of 15.21% beat Medifast's return on equity.